Sensei Biotherapeutics, Inc. (SNSE)

NASDAQ: SNSE · IEX Real-Time Price · USD

0.669

-0.002 (-0.30%)

At close: Jul 19, 2024, 4:30 PM

0.620

-0.049 (-7.32%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Sensei Biotherapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Selling, General & Admin	16.77	18.77	19.81	15.82	7.53	4.09	Upgrade
Research & Development	18.01	18.3	30.38	21.66	11.19	8.35	Upgrade
Other Operating Expenses	0	0	0	0	0.74	0	Upgrade
Operating Expenses	34.79	37.06	50.19	37.48	19.45	12.44	Upgrade
Operating Income	-34.79	-37.06	-50.19	-37.48	-19.45	-12.44	Upgrade
Interest Expense / Income	0.13	0.14	0.22	0.67	1.69	2.26	Upgrade
Other Expense / Income	-3	-3.11	-1.82	-1.36	-1.04	2.05	Upgrade
Pretax Income	-31.92	-34.1	-48.59	-36.79	-20.1	-16.74	Upgrade
Net Income	-31.92	-34.1	-48.59	-36.79	-20.1	-16.74	Upgrade
Preferred Dividends	0	0	0	0	0.1	3.8	Upgrade
Net Income Common	-31.92	-34.1	-48.59	-36.79	-20.2	-20.54	Upgrade
Shares Outstanding (Basic)	25	28	31	28	2	0	Upgrade
Shares Outstanding (Diluted)	25	28	31	28	2	0	Upgrade
Shares Change	-18.85%	-8.96%	10.80%	1618.88%	338.85%	-97.92%	Upgrade
EPS (Basic)	-1.21	-1.22	-1.58	-1.33	-12.53	-55.92	Upgrade
EPS (Diluted)	-1.21	-1.22	-1.58	-1.33	-12.53	-55.92	Upgrade
Free Cash Flow	-27.81	-32.04	-39.33	-31.97	-18.91	-8.62	Upgrade
Free Cash Flow Per Share	-1.11	-1.15	-1.28	-1.15	-11.73	-23.48	Upgrade
EBITDA	-29.05	-31.25	-45.83	-35.44	-18.2	-14.41	Upgrade
Depreciation & Amortization	2.74	2.71	2.54	0.69	0.21	0.07	Upgrade
EBIT	-31.79	-33.96	-48.37	-36.12	-18.41	-14.48	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).